Research / CMI / Fundamental state Inspectable configuration
State dimensions Filing 0000026172-26-000029 General Corporate
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.63% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.85% · OPTIONAL · VALID
Share-count growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.09% · CORE · VALID
Revenue growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.42% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
67.64% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
26.07% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.52% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.07% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Oct 3, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 2.25%
Current 2.63%
Delta 0.38% Cash Generation Increased
Previous 3.68%
Current 15.85%
Delta 12.17% Dilution Decreased
Previous 0.17%
Current -0.09%
Delta -0.26% Growth Increased
Previous 2.74%
Current 9.42%
Delta 6.68% Inventory Pressure Decreased
Previous 72.95%
Current 67.64%
Delta -5.30% Margin Decreased
Previous 26.71%
Current 26.07%
Delta -0.64% Profitability Increased
Previous 11.30%
Current 13.52%
Delta 2.22% R And D Intensity Decreased
Previous 4.26%
Current 4.07%
Delta -0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Dec 31, 2025
Similarity 72%
Compared 7 dimensions
Coverage 88% Growth 35.0 · Margin 5.0 · Profitability 20.0 · Capex Intensity 55.0 · Cash Generation 15.0 · R And D Intensity 10.0 · Inventory Pressure 20.0 Jun 30, 2025
Similarity 71%
Compared 8 dimensions
Coverage 100% Growth 35.0 · Margin 20.0 · Dilution 30.0 · Profitability 15.0 · Capex Intensity 15.0 · Cash Generation 35.0 · R And D Intensity 0.0 · Inventory Pressure 50.0 Sep 30, 2024
Similarity 70%
Compared 8 dimensions
Coverage 100% Growth 20.0 · Margin 0.0 · Dilution 5.0 · Profitability 5.0 · Capex Intensity 40.0 · Cash Generation 45.0 · R And D Intensity 10.0 · Inventory Pressure 55.0 Sep 27, 2020
Similarity 61%
Compared 8 dimensions
Coverage 100% Growth 35.0 · Margin 12.9 · Dilution 15.0 · Profitability 6.4 · Capex Intensity 19.3 · Cash Generation 5.0 · R And D Intensity 85.7 · Inventory Pressure 50.7 Sep 30, 2023
Similarity 61%
Compared 8 dimensions
Coverage 100% Growth 0.0 · Margin 30.0 · Dilution 35.0 · Profitability 55.0 · Capex Intensity 55.0 · Cash Generation 5.0 · R And D Intensity 55.0 · Inventory Pressure 35.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.